Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Emery

Showing results (71-80 of 733) with videos related to

Pageof 74
Sort By:
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 2, 2010
The changing management of inflammatory arthritisEdith Villeneuve, Lisa Hildebrandt, Paul Emery
Current Rheumatology Reports|September 24, 2009
The role of biomarkers in the management of patients with rheumatoid arthritisJackie Nam, Edith Villeneuve, Paul Emery
American Family Physician|November 19, 2003
Rheumatoid arthritisPaul Emery, Maria E Suarez-Almazor
American Family Physician|September 30, 2005
Advances in the treatment of early rheumatoid arthritisEdward M J Vital, Paul Emery
Best Practice & Research. Clinical Rheumatology|October 27, 2004
Imaging in early arthritisAmy Evangelisto, Richard Wakefield, Paul Emery
Expert Opinion on Drug Safety|November 17, 2018
Safety evaluation of adalimumab in immune-mediated inflammatory disorders: a rheumatological point of viewLaurence Duquenne, Hanna Gul, Paul Emery
The Journal of Rheumatology|December 3, 2019
How Are Rheumatologists Managing Anticyclic Citrullinated Peptide Antibodies-positive Patients Who Do Not Have Arthritis?Kulveer Mankia, Christopher Briggs, Paul Emery
Arthritis and Rheumatism|August 1, 2007
The validity of the inclusion of "lupus headache" in the Systemic Lupus Erythematosus Disease Activity IndexRichard Davey, John Bamford, Paul Emery
Expert Review of Clinical Immunology|May 19, 2010
Infliximab for rheumatoid arthritisBenazir Saleem, Sarah Mackie, Paul Emery
The New England Journal of Medicine|January 29, 2015
Etanercept tapering in rheumatoid arthritisPaul Emery, Mohammed Hammoudeh, Bernard Combe
Pageof 74

Showing results (71-80 of 733) with videos related to

Sort By:
Pageof 74
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 2, 2010
The changing management of inflammatory arthritisEdith Villeneuve, Lisa Hildebrandt, Paul Emery
Current Rheumatology Reports|September 24, 2009
The role of biomarkers in the management of patients with rheumatoid arthritisJackie Nam, Edith Villeneuve, Paul Emery
American Family Physician|November 19, 2003
Rheumatoid arthritisPaul Emery, Maria E Suarez-Almazor
American Family Physician|September 30, 2005
Advances in the treatment of early rheumatoid arthritisEdward M J Vital, Paul Emery
Best Practice & Research. Clinical Rheumatology|October 27, 2004
Imaging in early arthritisAmy Evangelisto, Richard Wakefield, Paul Emery
Expert Opinion on Drug Safety|November 17, 2018
Safety evaluation of adalimumab in immune-mediated inflammatory disorders: a rheumatological point of viewLaurence Duquenne, Hanna Gul, Paul Emery
The Journal of Rheumatology|December 3, 2019
How Are Rheumatologists Managing Anticyclic Citrullinated Peptide Antibodies-positive Patients Who Do Not Have Arthritis?Kulveer Mankia, Christopher Briggs, Paul Emery
Arthritis and Rheumatism|August 1, 2007
The validity of the inclusion of "lupus headache" in the Systemic Lupus Erythematosus Disease Activity IndexRichard Davey, John Bamford, Paul Emery
Expert Review of Clinical Immunology|May 19, 2010
Infliximab for rheumatoid arthritisBenazir Saleem, Sarah Mackie, Paul Emery
The New England Journal of Medicine|January 29, 2015
Etanercept tapering in rheumatoid arthritisPaul Emery, Mohammed Hammoudeh, Bernard Combe
Pageof 74